AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Biotech Innovation Dilemma
This chapter explores the evolving landscape of drug development through the lens of biotech companies Absci and Generate, focusing on their antibody candidates for COVID and asthma. It examines the skepticism surrounding the innovation and efficacy of AI-assisted drug design, as well as the broader implications of transparency in the biotech industry.